2017 International Congress Archives - Page 74 of 155

C19orf12 p.Thr11Met mutation is frequent among adult Turkish patients with MPAN

M. Quadri, S. Olgiati, O. Doğu, Z. Tufekcioglu, Y. Diler, E. Saka, M. Gultekin, H. Kaleagasi, D. Kuipers, J. Graafland, G. Breedveld, R. Sürmeli, G. Sünter, T. Doğan, A.D. Yalçın, B. Bilgiç, B. Elibol, M. Emre, H. Hanagasi, V. Bonifati (Rotterdam, Netherlands)
Caffeinated Drinks, LRRK2 Genotype and PD

C. Tanner, C. Marras, C. Meng, K. Marder, S. Bressman, R. Saunders-Pullman, R. Alcalay, E. Tolosa, A. Brice, S. Goldman, B. Schuele, A. Lang, S. Goldwurm, G. Riboldazzi, J. Ferreira, C. Klein, D. Berg, K. Brockmann, M. Tazir, J. Aasly, J. Marti-Masso, J. . Marti-Masso, R. Munhoz, C. Rieder, M. San Luciano, G. Mellick, C. Sue, K. Hasegawa, E. Tan, J. Langston, M. LRRK2 Cohort-Consortium (San Francisco, CA, USA)
Caffeine as a Treatment for Parkinson’s Disease: A Randomized Controlled Trial (CafePD)

R. Postuma, J. Anang, A. Pelletier, M. Moscovich, D. Grimes, A. Borys, S. Furtado, R. Munhoz, S. Cresswell, A. Moro, D. Hobson, L. Joseph, A. Lang (Montreal, QC, Canada)
Calcium Channel Blocking Drugs and Risk of LRRK2 Parkinson’s Disease

C. Marras, K. Marder, R. Alcalay, R. Saunders-Pullman, C. Meng, S. Goldman, A. Lang, M. Korell, M. San Luciano, E. Tolosa, B. Schuele, A. Brice, S. Goldwurm, G. Riboldazzi, C. Klein, G. Mellick, C. Sue, E.K. Tan, K. Brockmann, K. Hasegawa, S. Bressman, J. Ferreira, M. Tazir, W. Langston, D. Berg, C. Tanner (Toronto, ON, Canada)
Can glabellar and palmomental reflexes differentiate neurodegenerative from non-neurodegenerative parkinsonism?

X.X. Yu, X. Garcia, S. Patel, H. Fernandez (Cleveland, OH, USA)
Can the level of CSF Neurofilament Light Chain predict disease progression in Progressive Supranuclear Palsy?

E. Jabbari, J. Woodside, H. Morris (London, United Kingdom)
Can three-dimensional visual cues delivered via smart glasses reduce freezing of gait in patients with Parkinson’s Disease?

S. Janssen, J. Nonnekes, B. Bolte, M. Bittner, T. Heida, Y. Zhao, R. van Wezel (Enschede, Netherlands)
Cannabis and Parkinson’s Disease Tremor

L. Mischley, R. Bennett, M. Sexton, G. Ricciardi, J. McNames (Kenmore, WA, USA)
Capgras syndrome in advanced Parkinson disease

C. Groth, A. Pusso, D. Huss, S. Sperling, B. Shah, M. Harrison, W.J. Elias, G.F. Wooten, M. Barrett (Charlottesville, VA, USA)
CAPN1 mutations are associated with a syndrome of combined spasticity and ataxia

N. Brüggemann, V. Tadic, C. Klein, A. Münchau, K. Lohmann (Lübeck, Germany)
Cardiac 123I-MIBG Scintigraphy, olfactory testing and transcranial sonography for differentiating between Parkinson’s disease and atypical parkinsonian syndromes during the early stage

h. fujita, K. Suzuki, A. Numao, Y. Watanabe, T. Uchiyama, T. Miyamoto, M. Miyamoto, T. Kadowaki, K. Hirata (Shimotsuga-gun, Japan)
Cardiac Autonomic Dysregulation in Probable Multiple System Atrophy

M. Rukmani, R. Yadav, P. Pal, B. Bhaskarapillai, T. Sathyaprabha (Bangalore, India)
Cardiac-related pulsatility in white matter is associated with cognitive and motor performance in patients with Parkinson’s disease

Z. Shirzadi, H. Sharmarke, A. Robertson, A. Metcalfe, S. Duff-Canning, C. Marras, A. Lang, M. Masellis, B. MacIntosh (Toronto, ON, Canada)
Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients

A. Guekht, M. Lebedeva, G. Popov, A. Yakovlev, O. Davidov (Moscow, Russian Federation)
Case study: Real-time MRI articulatory comparison of a congenital aglossic and normal speaker

B. McMicken (Irvine, , CA, USA)
Catecholamines’ concentration ratio in plasma of early diagnosed treatment-naive patients with Parkinson disease

Z. Zalyalova, D. Khasanova (Kazan, Russian Federation)
Cause-Specific Hazard of Motor and Nonmotor Long Term Complications of Idiopathic Parkinson’s Disease in a Hospital-based Outpatient Clinic Incident Cohort of 1333 Patients

S. Prange, C. Laurencin, t. danaila, m.-b. delphine, S. Thobois (bron, France)
Causes, Complications and Outcomes of Hospitalization in Patients with Dementia with Lewy Bodies

C. Spears, A. Besharat, D. Martinez-Ramirez, L. Almeida, M. Armstrong (Gainesville, FL, USA)
CB2R agonist AM1241 reverses the development of MPTP-induced PD and activates the regeneration of DA neurons

R. Zhu (Shanghai, China)
Cefepime-induced encephalopathy and myoclonus

T. Rasameesoraj, X.x. Yu, A. Ahmed, H. Fernandez (Cleveland, OH, USA)
Central Aortic Pressure in Parkinson’s Disease and Levodopa Effect

M. BALAL, M. DEMIRKIRAN (Adana, Turkey)
Central pain processing in “drug-naïve” pain-free patients with Parkinson’s disease

R. De Micco, A. Russo, F. Esposito, A. Giordano, M. Fratello, G. Caiazzo, M. Cirillo, G. Tedeschi, A. Tessitore (Naples, Italy)
Cerebellar Ataxia – The First Symptom of HIV Infection

L. Beltrami, J. Kristochik, M. Novaes, G. Tansini, F. Germiniani, H. Teive (Curitiba, Brazil)
Cerebello-cortical loops differ between Essential-, Parkinsonian- and voluntary tremor

J. Raethjen, M. Muthuraman, S. Groppa, G. Deuschl (Kiel, Germany)
Cerebrospinal fluid biomarkers in Huntington’s disease – a longitudinal study

V. Niemelä, J. Sundblom, A.-M. Landtblom, S. Herman, K. Kultema, D. Nyholm, K. Blennow (Uppsala, Sweden)
Cerebrospinal Fluid Levels of Coenzyme Q10 are Reduced in Multiple System Atrophy

Y. Compta, F. Antonelli, M. Fernandez, P. Bravo, M. Soto, A. Camara, D.M. Giraldo, M.J. Marti, On-behalf-of Catalan-MSA-Registry Group (Barcelona, Spain)
Cerebrospinal fluid lysosomal enzymes and cognition in Parkinson’s disease

M. Delgado-Alvarado, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, P. Martínez-Lage, A. Izagirre, S. Paciotti, L. Parnetti, P. Calabresi, T. Beccari, M. Rodriguez-Oroz (San Sebastián, Spain)
Cerebrotendinous xanthomatosis without tendon xanthoma: a diagnostic challenge.

S. Souki, L. Vasconcellos, M. Spitz, J. Pereira, V. Marussi, A. Carrié, P. Couvert (Rio de Janeiro, Brazil)
Changes in Functioning Associated with Exercise in Individuals with Parkinson’s

L. Clack, B. Riemann, M. Cohen (Savannah, GA, USA)
Changes in motor subtype designation of early Parkinson’s disease patients

R. Eisinger, D. Martinez-Ramirez, C. Hess, M. Okun, A. Gunduz (Gainesville, FL, USA)
Changes in saccade performance with oculomotor task repetition in neurological disorders

Y. Terao, H. Fukuda, S.-i. Tokushige, S. Inomata-Terada, Y. Ugawa (Tokyo, Japan)
Changing patterns of intimate relationships as dementia emerges in Parkinson’s disease

S. Vatter, K. McDonald, S. McCormick, I. Leroi (Manchester, United Kingdom)
Characteristics of tremor caused by non-olivary lesion of the medulla oblongata

A. Kovács, N. Pintér, L. Halász, A. Kamondi (Budapest, Hungary)
Characterization of GNB1 mutations as a cause of global developmental delay in combination with dystonia, ataxia, or chorea in children

H. Baumann, I. Masuho, D. Patil, S. Steinruecke, E. Hebert, V. Dobricic, I. Huening, G. Gillessen-Kaesbach, A. Westenberger, D. Savic-Pavicevic, A. Muenchau, C. Klein, A. Rolfs, K. Martemyanov, K. Lohmann (Luebeck, Germany)
Characterization of Noncoding Variant(s) Driving Genome-Wide Association of the PARK10 Locus in Autopsy-Proven Parkinson Disease and Controls.

J. Vance, K. Nuytemans, D. Gveric, L. Gomez, G. Beecham, E. Martin, W. Scott (Miami, FL, USA)
Characterization of Pisa syndrome in Parkinson’s disease.

T. Clark, J. Nutt, F. Horak, M. Mancini, M. Jurado, T. Hullar (Portland, OR, USA)
Characterizing task-based acoustic variations of vowels in Parkinson’s disease: Preliminary data

C. Kuo (Harrisonburg, VA, USA)
Characterizing the Bcl-2 Associated Athanogene 5 Interactome

E. Friesen, X. Wang, D. Williams, H. Chau, M. De Snoo, O. Pellerito, L. Kalia, G. Schmitt-Ulms, S. Kalia (Toronto, ON, Canada)
Cholinergic activity, mobility, and attention in mild cognitive impairment

D. Martini, K. Smulders, A. Hiller, K. Chung, J. Quinn, F. Horak (Portland, OR, USA)
Chorea and psychosis as stroke presentation : report and brief review

F. RADJI (AGEN, France)
Cinnamomum verum on Learning and Memory in Wistar Albino Rats

N. AHMED, D. AGRAWAL, A. CHUGHTAI (ALIGARH, India)
Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

K. Fifel (Leiden, Netherlands)
Citrus extract A protects dopaminergic neuron by modulating mitochondrial respiration and reactive oxygen species

Y. Jang, J. Han, S.J. Kim, M.J. Lee, I. Ryu, X. Ju, H. Chu, M.J. Ryu, E.S. Oh, S.-Y. Choi, W. Chung, J.Y. Heo, G.R. Kweon (Daejeon, Republic of Korea)
Classification of neurocognitive impairment in Spanish speaking Parkinson’s disease patients

S. Anderson, C. Bermudez, N. Sun-Suslow, L. Segala, H. Moore, C. Singer, J. Jagid, G. Rey, B. Levin (Chicago, IL, USA)
Clean intermittent catheterization in Parkinson’s disease: a case report

M. Tosin, C. Mecone, W. Macedo, A.P. Seabra, A. Barbosa, R. Sakakibara (RIO DE JANEIRO, Brazil)
Clinical analysis of patients with servical dystonia who Botulinum toxin injection is performed: 10 years experience of Ege University Neurology Department of Movement Disorders Clinic

A. Acarer, S. Ciftci, Z. Colakoglu (Izmir, Turkey)
Clinical and demographics of cervical dystonia related to the direction of the neck movement

K. Asanuma (Kyoto, Japan)
Clinical and electrophysiological features of seven patients with moving toes syndrome: Is it a type of spinal segmental myoclonus?

G. Kiziltan, H. Kurucu, C. Yalcinkaya, A. Gunduz, M. E. Kiziltan (Istanbul, Turkey)
Clinical and genetic analysis of ataxic patients with CACNA1A mutations in Taiwan

P.-Y. Fong, S.-C. Lai, T.-H. Yeh, C.-S. Lu (Taoyuan City, Taiwan)
Clinical and genetic characterization of Huntington’s disease in relation to the age and type of onset.

L. Mendoza Vega, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. De-la-Cruz-Landero, N. Davila-Avila, K. Salinas-Barboza, S. Isais-Millan (Mexico City, Mexico)
Clinical and Imaging and phenoconversion in the PARS prodromal cohort

K. Marek, A. Siderowf, S. Eberly, D. Oakes, M. Stern, D. Russell, J. Seibyl, D. Jennings (New Haven, CT, USA)
Clinical characteristics of cognitive impairment in patients with Parkinson’s disease and its related pattern in 18F-FDG PET imaging

F.-t. Liu, J.-j. Ge, L. Wu, Y.-j. Yang, J. Zhao, S.-s. Luo, Y.-m. Sun, J.-j. Wu, Z.-t. Ding, C.-t. Zuo, J. Wang (Shanghai, China)
Clinical characteristics of Parkinson’s disease developed from essential tremor

D.-W. Ryu, J.-S. Kim, K.-S. Lee, J.-W. Park (Seoul, Republic of Korea)
Clinical characteristics of scan without evidence of dopaminergic deficits (SWEDDs) in Japan.

M. Takahashi, Y. Tashiro, N. Ito, T. Sato, T. Sekiguchi, A. Inaba, S. Orimo (Tokyo, Japan)
Clinical correlates of severe somnolence in Parkinson’s disease: results from an international naturalistic non-motor symptoms cohort

R. Taddei, A. Sauerbier, M. Qamar, K. Ray Chaudhuri (London, United Kingdom)
Clinical Criteria for Subtyping Parkinson’s Disease: Differences in imaging and CSF biomarkers and longitudinal progression

S.-M. Fereshtehnejad, Y. Zeighami, A. Dagher, R. Postuma (Montreal, QC, Canada)
Clinical effects are persistent at the end of one abobotulinumtoxinA injection cycle in cervical dystonia – results from a meta-analysis of 1091 subjects

R. Trosch, V. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)
Clinical Experience with Initiation of Carbidopa/Levodopa Enteral Suspension in Parkinson’s Disease Patients with Cognitive Impairment

P. Dowell, K. Lyons, R. Pahwa (Kansas City, KS, USA)
Clinical feasibility of a wearable, conformable, sensor patch to monitor motor symptoms in Parkinson’s disease

B. Boroojerdi, K. Claes, R. Ghaffari, N. Mahadevan, M. Markowitz, K. Melton, B. Morey, C. Otoul, S. Patel, J. Phillips, E. Sen-Gupta, O. Stumpp, D. Tatla, J. Wright Jr, N. Sheth (Monheim am Rhein, Germany)
Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm

S. Pandey, S. Jain (New Delhi, India)
Clinical Phenotype in Patients with Multiple System Atrophy in the Mexican Population

S. Isais-Millán, C. Perez-Lohman, K. Salinas Barboza, A. Cervantes Arriaga, M. Rodriguez Violante, L. Mendoza Vega, N. Davila Avila, A. DelaCruz Landero (Mexico City, Mexico)
Clinical Predictors of Dementia and Other Non-Motor Symptoms in Parkinson’s Disease

D. Lichter, S. Finnegan (Buffalo, NY, USA)
Clinical profile of patients with blepharospasm

S. Kaleagasi, O. Dogu (Mersin, Turkey)
Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study

K. Dashtipour, Z. Mari, J. Jankovic, C. Adler, M. Schwartz, M. Brin (Loma Linda, CA, USA)
Clinical utility of chronic directional subthalamic Deep Brain Stimulatoin in Parkinson’s Disease

C. Hartmann, L. Venkatesan, P. Slotty, J. Vesper, A. Schnitzler (Düsseldorf, Germany)
Clinical Utility of Optimized Parameters for a Quantitative Analysis of 123I-ioflupane SPECT (DaTscan) Images

G. Zubal, S. Tinaz, C. Chow, H. Blumenfeld, E. Louis (New Haven, CT, USA)
Clinical utility of visualization of Nigrosome-1 in patients with Parkinson’s disease

A. Sunny, R. Naduthota, R. Botta, S. Varadharajan, J. Saini, R. Yadav, P. Pal (Bangalore, India)
Clinicopathological analysis of corticobasal syndrome: a retrospective study

R. Lamb, J. Rohrer, R. Weil, H. Ling, A. Lees, H. Morris (London, United Kingdom)
CLOCK rs1801260 polymorphism is associated with suscepibilty of Parkinson’s disease in Chinese population

F. Lou, X. Luo, M. Li, Y. Ren (Shenyang, China)
CLOCK varriant correlates to motor fluctuation and sleep disorders in Chinese patients with Parkinson’s disease

F. Lou, X. Luo, M. Li, Y. Ren (Shenyang, China)
Closed Loop STN DBS for Tremor in Parkinson’s disease using a Neural or Kinematic Signal

A. Velisar, J. Herron, J. SYRKIN-NIKOLAU, Z. Blumenfeld, M. TRAGER, T. MARTIN, H. CHIZECK, H. Bronte-Stewart (Palo Alto, CA, USA)
Co-speech gestures in Parkinson’s disease (PD)

M. Bacigalupe (La Plata, Argentina)
Cognition in the PREDICT-PD Cohort

A. Nagy, E. Hardaker, J. Bestwick, G. Giovannoni, T. Warner, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)
Cognitive and demographic predictors of progression to MCI and dementia in Parkinson’s disease

B. Cholerton, C. Johnson, B. Fish, J. Quinn, K. Chung, A. Peterson-Hiller, L. Rosenthal, T. Dawson, M. Albert, S.-C. Hu, T. Montine, J. Leverenz, C. Zabetian, K. Edwards (Stanford, CA, USA)
Cognitive changes and cortical thinning evolution of parkinson’s disease patients: 4-year-follow up.

A. Campabadal, C. Uribe, B. Segura, H. Baggio, A. Abos, A. Garcia-Diaz, M.-J. Marti, Y. Compta, F. Valldeoriola, C. Junque (Barcelona, Spain)
Cognitive data in the Parkinson’s Progression Markers Initiative: Comparison of normative data approaches

K. Wyman-Chick, M. Barrett, P. Martin, C. Manning, S. Sperling (Charlottesville, VA, USA)
Cognitive Dysfunction is Associated with Greater Imbalance and Falls in Patients with Essential Tremor

E. Louis, K. Collins, S. Kellner, S. Morgan, B. Rohl, E. Huey, S. Cosentino (New Haven, CT, USA)
Cognitive effects of GPi versus STN deep brain stimulation in Parkinson’s Disease: experience with patients with moderate cognitive impairment

C. Marques-Matos, C. Sousa, J. Lima, P. Monteiro, P. Linhares, R. Vaz, M.J. Rosas (Porto, Portugal)
Cognitive function and impulsive-compulsive behaviors in Parkinson’s disease motor subtypes

S.-C. Yao, P.-N. Wang, K.-K. Liao, D.-E. Shan (Taipei, Taiwan)
Cognitive Function is Preserved 10 Years Following DBS in People with Dystonia

E. Hogg, J. Eskenazi, E. During, J. Wertheimer, R. Alterman, M. Tagliati (Los Angeles, CA, USA)
Cognitive impairment in early onset and familial Parkinson’s disease.

M. Tan, J. Bras, J. Hong, C. Brugaletta, T. Samakomva, K. Hoffmann, S. Lubbe, D. Grosset, N. Wood, A. Schapira, J. Hardy, H. Houlden, H. Morris (London, United Kingdom)
Cognitive Impairment in MSA Patients from the Catalan Multiple System Atrophy Registry (CMSAR)

D. Giraldo, Y. Compta, F. Antonelli, E. Muñoz, A. Camara, J. Pagonabarraga, O. de Fabregués, J. Hernández-Vara, F. Valldeoriola, E. Tolosa, M.C. Pont, S. Jauma, A. Bayes, N. Caballol, M. Calopa, P. Pastor, L. Planellás, M. Pujol, V. Puente, A. Avila, M.J. Martí (Barcelona, Spain)
Cognitive Mechanisms of Visual Dysfunction in Non-Demented PD Patients (PD-ND)

T. Lin, H. Gibler, S. Rapcsak (Tucson, AZ, USA)
Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study

E. Fiorenzato, L. Weis, A. Antonini, R. Biundo (Venice-Lido, Italy)
Cognitive safety of eight-hours adaptive deep brain stimulation (aDBS) in Parkinson’s disease

R. Ferrucci, F. Ruggiero, F. Cortese, T. Bocci, M. Rosa, M. Arlotti, M. Colombo, S. Marceglia, F. Mameli, F. Cogiamanian, G. Ardolino, M. Locatelli, P. Rampini, A. Priori (Milan, Italy)
Cognitive strategy use during daily activities in people with Parkinson’s Disease

I. Sturkenboom, E. Steultjens, M. Nott, C. Chapparo (Nijmegen, Netherlands)
Combination of multimodal neuroimaging techniques is useful to diagnose multiple system atrophy

K. Abe, K. Fukushima, k. Ando, Y. Maeda, N. Kotoura, R. Ishikura, H. Yoshikawa (Nishinomiya, Japan)
Combined aerobic and function-based exercise in a group setting improves quality of life and functional mobility in persons with Parkinson disease

J. Russell, L. Wolf, T. McMath, L. Shaffer, C. Collins, A. Mansur, D. Zid, D. Hinkle (Columbus, OH, USA)
Combined effects of rTMS and botulinum toxin therapy in benign essential blepharospasm

A. Wagle Shukla, J. Legacy, W. Deeb, W. Hu (Gainesville, FL, USA)
Combined Motor and Cognitive Training Improves Motor and Cognitive Function in People with Parkinson’s Disease and Freezing of Gait

C. Fearon, I. Killane, L. Newman, R. Beck, T. Munteanu, D. Birsanu, J. Butler, B. Magennis, R. Reilly, T. Lynch (Dublin 7, Ireland)
Combined Surgical Therapies for Optimal Management of Advanced Parkinson’s Disease

L. Kirkpatrick, Y. Torres-Yaghi, A. Keys, N. Starr, T. Kimbason, C. Moussa, F. Amjad, F. Pagan (Washington, DC, USA)
Communication Calendar for Interdisciplinary Therapy of Parkinson’s Disease

F. Adib Saberi, D. Dressler (Hamburg, Germany)
Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness

A. Cucca, M. Biagioni, J. Golomb, J. Fleisher (New York, NY, USA)
Comparative Age-Relatedness of Dyskinesia, Dystonia and Ataxia Rating Scales in Healthy Children

M. Kuiper, R. Brandsma, L. Vrijenhoek, H. Burger, D. Sival (Groningen, Netherlands)
Comparison of hand functions between people with Parkinson’s disease and healthy subjects

M. Mak, I. Wong (Hong Kong, Hong Kong)
Comparison of lead localization in postoperative CT versus MRI

R. Nickl, M. Reich, P. Fricke, F. Steigerwald, F. Lange, R.-I. Ernestus, J. Volkmann, C. Matthies (Würzburg, Germany)
Comparison of neuropathology in Parkinson’s disease subjects with and without deep brain stimulation

G. Pal, B. Ouyang, G. Serrano, H. Shill, C. Goetz, G. Stebbins, L. Metman, E. Driver-Dunckley, S. Mehta, J. Caviness, M. Sabbagh, C. Adler, T. Beach (Chicago, IL, USA)
Comparison of neurotoxic potency of a newly produced Botulinum Neurotoxin Type A with onabotulinumtoxinA, incobotulinumtoxinA and BotulinumtoxinA

Y. Feng, W. Liu, L. Pan, Z. Nie (Shanghai, China)
Comparison of pallidal and subthalamic deep brain stimulation in Parkinson’s disease: therapeutic and adverse effects

H.-S. Ryu, M.-S.K. Kim, S. You, M.-J.K. Kim, Y.J. Kim, J. Kim, K. Kim, S.J. Chung (Seoul, Republic of Korea)
Comparison of subthalamic and pallidal deep brain stimulation in treatment of Parkinson’s disease: a 5-year follow-up study

A. Gamaleya, A. Tomskiy, A. Dekopov, E. Bril, A. Poddubskaya, N. Fedorova, V. Shabalov (Moscow, Russian Federation)
Comparison of the effect of thalamic DBS/coagulation on tremor and thalamic neuronal activity in spinocerebellar ataxia and essential tremor

T. Hashimoto, A. Muralidharan, K. Yoshida, T. Goto, T. Yako, K. Baker, J. Vitek (Matsumoto, Japan)
Comparison of the non-motor symptom assessment scale between LRRK2 G2019S positive versus matched control Parkinson disease

S. Gunzler, S. Mittal, C. Tatsuoka, A. Wilson-Delfosse, S. Chen, J. Mieyal, I.J. Feng, D. Riley (Cleveland, OH, USA)
Compulsive sexual behaviour in Parkinson’s disease is associated with higher doses of levodopa

P. Barbosa, T. Warner, A. Djamshidian (London, United Kingdom)
Congenital mirror movements: When the left hand doesn’t know what the right is doing

M. Boca, A. Whone (Bristol, United Kingdom)
Connectivity patterns in frontal cognitive regions in Parkinson’s disease

A. Hanganu, A. Nagano-Saito, A. Tam, N. Auclair-Ouellet, S. Jobert, B. Mejia-Constain, D. Schoemaker, C. Degroot, A.-L. Lafontaine, H. Chertkow, P. Bellec, O. Monchi (Calgary, AB, Canada)
Consideration of the relationship between severity of Parkinson’s disease and cognitive function, depression, quality of life

M. Saruwatari, M. Sagawa, A. Kumon, K. Hasegawa (Sagamihara, Japan)
Contact location and non-motor outcomes in subthalamic nucleus deep brain stimulation for Parkinson’s disease

D. Floden, C. Matias, C. Wathen, G. Ozinga, O. Hogue, A. Machado (Cleveland, OH, USA)
Correction of minimal oculomotor disorders improves forward and lateral axial dystonia in Pakinson’s disease

S. Varanese, M. Meglio, M. Bologna, M. Santilli, G. Grillea, F. Lena, L. Meglio, N. Modugno (Pozzilli, Italy)
Correlation analysis between dopamine release in striatal sub-regions and motor impairment in Parkinson’s disease subjects

I. Klyuzhin, M. Sacheli, N. Vafai, E. Shahinfard, B. Lakhani, J. Neva, J. Fu, J. McKenzie, N. Neilson, K. Dinelle, L. Boyd, A. Stoessl, V. Sossi (Vancouver, BC, Canada)
Correlation and impact of non-motor symptoms on intensity of motor symptoms in Parkinson’s Disease

M. Sanoeva, M. Gulova, N. Mansurova (bukhara, Uzbekistan)
Correlation Between Time Course, Level of Impact of Illness, Functionality, and Postural Measures of Patients with Cervical Dystonia.

F. Germiniani, S. Mattozo, R. Werle, A. Guimarães, H. Teive (Curitiba, Brazil)
Correlation of Electrode Position and Clinical Outcomes in Globus Pallidus Stimulation for Dystonia

H. Park (Seoul, Republic of Korea)
Correspondence between MRI borders of the subthalamic nucleus and its electrophysiological borders: a comparison study using intraoperative CT.

S. Bus, P. Van den Munckhof, M. Bot, G. Pal, B. Ouyang, S. Sani, L. Verhagen-Metman (Chicago, IL, USA)
Cortical excitability during a movement compared with postural control task in healthy subjects

F. Chang, P. Menon, M. VanDen Bos, M. Kiernan, S. Vucic, V. Fung (Sydney, Australia)
Cortical phase-amplitude coupling across Parkinson’s disease phenotypes measured with magnetoencephalograph

J. Bajwa, E. Peña, L. Rosedahl, T. Mohammed, F. Almohammed, T. AlOtaibi, L. Soualmi, V. Poghosyan, S. Cooper, V. Jousmäki, M. Johnson (Riyadh, Saudi Arabia)
Cortico-thalamic Biomarkers for a Responsive Deep Brain Stimulation: an enhanced Treatment of Essential Tremor.

E. Opri, J. Shute, R. Molina, K. Foote, M. Okun, A. Gunduz (Gainesville, FL, USA)
Corticobasal degeneration and frontotemporal dementia – an overlapping continuum

R. Varela, C. Duque, J. Carvalho, A. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)
Corticobasal syndrome due to brain tumor

P. Tsitsi, G. Xiromerisiou, T. Kalantzakou, T. Bourinaris, G. Deretzi (Stockholm, Sweden)
Corticospinal tract dysfunction precede the cerebellar syndrome in spinocerebellar ataxia 2

R. Rodríguez-Labrada, L. Velázquez-Pérez, R. Torres-Vega, J. Medrano-Montero, Y. Vázquez-Mojena, G. Auburger, U. Ziemann (Holguín, Cuba)
Cost-utility analysis of flexible interval incobotulinumtoxinA versus onabotulinumtoxinA in the management of blepharospasm and cervical dystonia in Ontario, Canada.

M.-E. Gendron, M.-E. Gendron, R. Kazerooni (Burlington, ON, Canada)
CR6-interacting factor1 Deficiency in Dopamine Neurons Triggers Early-onset Parkinsonism in Mice

I. Ryu, J. Han, Y. Jang, S.J. Kim, j. Kim, M.J. Lee, X. Ju, M.J. Ryu, S.-Y. Choi, W. Chung, E. Oh, G.R. Kweon (Daejeon, Republic of Korea)
Creutzfeldt-Jakob Disease with Corticobasal Syndrome-Like Onset: Case report

M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)
CSF, plasma and saliva alpha-Synuclein in moderately advanced Parkinson’s disease cohort: the BioFIND study

R. Alcalay, A. Amara, P. Taylor, H. Andrews, J. Goldman, T. Xi, P. Tuite, C. Henchcliffe, P. Hogarth, S. Frank, M.-H. Saint Hilaire, A. Naito, M. Frasier, V. Arnedo, A. Reimer, M. Sutherland, C. Swanson-Fischer, K. Gwinn, U. Kang (NYC, NY, USA)
Curcumin I prevents the developmental defective sensorimotor patterns resulted from Lead poisoning in rat

H. BENAMMI, O. EL HIBA, H. GAMRANI (Marrakech, Morocco)
Curcumin I protect against copper induced neurobehavioral features of Parkinson’s disease in rat

A. Abbaoui, O. EL Hiba, H. Gamrani (Marrakech, Morocco)